Evidence map›Paper›PMID 38501821›Full record

ArticleMicrobiology spectrum2024

Fatty acids of

Mark S McClain, William E Boeglin, Holly M Scott Algood, Alan R Brash

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Challenges and Prospects for Eradication ofPathogens (Basel, Switzerland) · 2025
    Review
  3. Species-specific components of theInfection and immunity · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mark S McClainDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0002-9857-4883
William E BoeglinDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Holly M Scott AlgoodDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0003-3735-4649
Alan R BrashDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infectionR21AI163586 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALGOOD, HOLLY MARIE SCOTT, MCCLAIN, MARK S · 2022 to 2023
$491k
The role of Th17 cytokines in H.pylori infectionI01BX000915 · VA · VETERANS HEALTH ADMINISTRATION · PI HOLLY Marie Scott ALGOOD · 2011 to 2026
–
BLRD VA I01 BX000915NCI NIH HHS P30 CA068485NIAID NIH HHS R21 AI163586
6 · The paper itself

Abstract

Bacterial lipoproteins are post-translationally modified by the addition of acyl chains that anchor the protein to bacterial membranes. This modification includes two ester-linked and one amide-linked acyl chain on lipoproteins from Gram-negative bacteria.

Indexed as

Bacterial ProteinsFatty AcidsHelicobacter pyloriLipoproteinsGas Chromatography-Mass SpectrometryHelicobacter InfectionsHumansImmunity, InnatePhospholipidsBacterial ProteinsFatty AcidsLipoproteinsPhospholipidsacyltransferasesHelicobacter pylorilipoproteinsphospholipidsposttranslational protein modificationToll-like receptor 2

Identifiers

PMID38501821
PMCPMC11064636
OpenAlexW4392953703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.